1. Home
  2. ZURA vs ATPC Comparison

ZURA vs ATPC Comparison

Compare ZURA & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • ATPC
  • Stock Information
  • Founded
  • ZURA 2022
  • ATPC 2016
  • Country
  • ZURA United States
  • ATPC Malaysia
  • Employees
  • ZURA N/A
  • ATPC N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • ATPC Medical/Nursing Services
  • Sector
  • ZURA Health Care
  • ATPC Health Care
  • Exchange
  • ZURA Nasdaq
  • ATPC Nasdaq
  • Market Cap
  • ZURA 69.9M
  • ATPC 68.0M
  • IPO Year
  • ZURA N/A
  • ATPC N/A
  • Fundamental
  • Price
  • ZURA $1.31
  • ATPC $1.47
  • Analyst Decision
  • ZURA Buy
  • ATPC
  • Analyst Count
  • ZURA 7
  • ATPC 0
  • Target Price
  • ZURA $14.33
  • ATPC N/A
  • AVG Volume (30 Days)
  • ZURA 708.2K
  • ATPC 55.8K
  • Earning Date
  • ZURA 08-08-2025
  • ATPC 08-13-2025
  • Dividend Yield
  • ZURA N/A
  • ATPC N/A
  • EPS Growth
  • ZURA N/A
  • ATPC N/A
  • EPS
  • ZURA N/A
  • ATPC N/A
  • Revenue
  • ZURA N/A
  • ATPC $1,293,141.00
  • Revenue This Year
  • ZURA N/A
  • ATPC N/A
  • Revenue Next Year
  • ZURA N/A
  • ATPC N/A
  • P/E Ratio
  • ZURA N/A
  • ATPC N/A
  • Revenue Growth
  • ZURA N/A
  • ATPC N/A
  • 52 Week Low
  • ZURA $0.97
  • ATPC $0.90
  • 52 Week High
  • ZURA $5.07
  • ATPC $6.80
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 59.63
  • ATPC 45.37
  • Support Level
  • ZURA $1.00
  • ATPC $1.37
  • Resistance Level
  • ZURA $1.45
  • ATPC $1.47
  • Average True Range (ATR)
  • ZURA 0.10
  • ATPC 0.09
  • MACD
  • ZURA 0.03
  • ATPC 0.02
  • Stochastic Oscillator
  • ZURA 68.89
  • ATPC 47.48

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

Share on Social Networks: